Literature DB >> 19404646

Increased expression of CD154 and FAS in SLE patients' lymphocytes.

Maria Elena Manea1, Ruediger B Mueller, Doru Dejica, Ahmed Sheriff, Georg Schett, Martin Herrmann, Peter Kern.   

Abstract

An increased level of apoptotic material and B cell activation leading to autoantibody production are hallmarks of systemic lupus erythematoses (SLE). Increased FAS expression, apoptosis, and CD154-mediated signaling, enabling T–B cell interaction are involved in the pathogenesis of SLE. This study addresses the expression profile of CD154 and FAS in the peripheral blood of patients with SLE, rheumatoid arthritis (RA) and normal healthy control donors. Surface markers on peripheral blood T and B cells from patients and healthy control donors were assessed using flow cytometry. The expression of CD154 and FAS were significantly increased in T and B cells of SLE patients as compared to healthy control donors and RA patients. In SLE and RA patients, FAS expression strongly correlated with CD154 expression on T cells, which was not found in healthy control donors. FAS expression was also associated with the occurrence of anti-DNA antibodies. We demonstrate high CD154 and FAS expression as a characteristic feature of SLE. This pattern may reflect simultaneous activation of apoptosis and activation of B–T cell interaction in SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404646     DOI: 10.1007/s00296-009-0933-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  The CD40 ligand expressed by human B cells costimulates B cell responses.

Authors:  A C Grammer; M C Bergman; Y Miura; K Fujita; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.

Authors:  M Nakamura; Y Tanaka; T Satoh; M Kawai; M Hirakata; J Kaburaki; Y Kawakami; Y Ikeda; M Kuwana
Journal:  Rheumatology (Oxford)       Date:  2005-09-27       Impact factor: 7.580

Review 3.  Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Authors:  N Suzuki; M Ichino; S Mihara; S Kaneko; T Sakane
Journal:  Arthritis Rheum       Date:  1998-02

4.  Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation.

Authors:  J P Haas; M Grunke; C Frank; W Kolowos; D Dirnecker; G Leipold; T Hieronymus; H M Lorenz; M Herrmann
Journal:  Cell Death Differ       Date:  1998-09       Impact factor: 15.828

5.  Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.

Authors:  R K Vakkalanka; C Woo; K A Kirou; M Koshy; D Berger; M K Crow
Journal:  Arthritis Rheum       Date:  1999-05

Review 6.  Impaired clearance of dying cells in systemic lupus erythematosus.

Authors:  Udo S Gaipl; Reinhard E Voll; Ahmed Sheriff; Sandra Franz; Joachim R Kalden; Martin Herrmann
Journal:  Autoimmun Rev       Date:  2004-12-08       Impact factor: 9.754

7.  The soluble CD40 ligand sCD154 in systemic lupus erythematosus.

Authors:  K Kato; E Santana-Sahagún; L Z Rassenti; M H Weisman; N Tamura; S Kobayashi; H Hashimoto; T J Kipps
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Authors:  A Desai-Mehta; L Lu; R Ramsey-Goldman; S K Datta
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

9.  Cytokine transcriptional events during helper T cell subset differentiation.

Authors:  J A Lederer; V L Perez; L DesRoches; S M Kim; A K Abbas; A H Lichtman
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.

Authors:  E J Schattner; K B Elkon; D H Yoo; J Tumang; P H Krammer; M K Crow; S M Friedman
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  5 in total

1.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

Review 2.  Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.

Authors:  Annegret Kuhn; Jörg Wenzel; Heiko Weyd
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 10.817

3.  Compelling Evidence Linking CD40 Gene With Graves' Disease in the Chinese Han Population.

Authors:  He Jiang; Fei-Fei Yuan; Hai-Ning Wang; Wei Liu; Xiao-Ping Ye; Shao-Ying Yang; Hui-Jun Xie; Sha-Sha Yu; Yu-Ru Ma; Le-Le Zhang; Shuang-Xia Zhao; Huai-Dong Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-18       Impact factor: 5.555

Review 4.  Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Authors:  Isaac T W Harley; Kristen Allison; R Hal Scofield
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

5.  Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.

Authors:  Ramya Sivakumar; Georges Abboud; Clayton E Mathews; Mark A Atkinson; Laurence Morel
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.